NCT06428643 A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
| NCT ID | NCT06428643 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tulane University |
| Condition | Chlamydia |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,322 participants |
| Start Date | 2025-08-14 |
| Primary Completion | 2028-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,322 participants in total. It began in 2025-08-14 with a primary completion date of 2028-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study includes testing for four STIs (chlamydia, gonorrhea, syphilis, and HIV) at no cost. If positive, individual subjects will also be counseled and offered options for treatment for themselves and their sex partners that may include no cost expedited treatment and the option to be rescreened 3 months after treatment.
Eligibility Criteria
Inclusion Criteria: * Identifies as African American or Black * 15-26 years of age * Lives or spends most of their time in Orleans Parish * Had vaginal sex at least once Exclusion Criteria: * Unwilling or unable to provide informed consent * Unable to speak or understand English * Previously enrolled in the study * Known to be pregnant * Known HIV positive status
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06428643 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 26 Years, studying Chlamydia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06428643 currently recruiting?
Yes, NCT06428643 is actively recruiting participants. Contact the research team at kissing@tulane.edu for enrollment information.
Where is the NCT06428643 trial being conducted?
This trial is being conducted at New Orleans, United States.
Who is sponsoring the NCT06428643 clinical trial?
NCT06428643 is sponsored by Tulane University. The trial plans to enroll 2,322 participants.